ImmuCell (ICCC) Short Interest Ratio & Short Volume → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free ICCC Stock Alerts $5.03 +0.03 (+0.60%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media ImmuCell Short Interest DataCurrent Short Volume4,500 sharesPrevious Short Volume6,100 sharesChange Vs. Previous Month-26.23%Dollar Volume Sold Short$22,725.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares7,820,000 sharesFloat Size5,580,000 sharesShort Percent of Float0.08%Today's Trading Volume5,994 sharesAverage Trading Volume9,403 sharesToday's Volume Vs. Average64% Short Selling ImmuCell ? Sign up to receive the latest short interest report for ImmuCell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatICCC Short Interest Over TimeICCC Days to Cover Over TimeICCC Percentage of Float Shorted Over Time Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details ImmuCell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,500 shares $22,725.00 -26.2%0.1%0.6 $5.05 3/31/20246,100 shares $32,330.00 -4.7%0.1%0.8 $5.30 3/15/20246,400 shares $33,600.00 +1.6%0.1%0.8 $5.25 2/29/20246,300 shares $33,075.00 -20.3%0.1%0.8 $5.25 2/15/20247,900 shares $39,697.50 +5.3%0.1%0.9 $5.03 1/31/20247,500 shares $39,825.00 -2.6%0.1%0.8 $5.31 Get the Latest News and Ratings for ICCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,700 shares $39,347.00 -13.5%0.1%0.6 $5.11 12/31/20238,900 shares $45,301.00 +30.9%0.2%0.8 $5.09 12/15/20236,800 shares $31,144.00 +13.3%0.1%0.5 $4.58 11/30/20236,000 shares $27,240.00 -7.7%0.1%0.4 $4.54 11/15/20236,500 shares $32,825.00 -52.2%0.1%0.4 $5.05 10/31/202313,600 shares $68,680.00 +70.0%0.3%0.8 $5.05 10/15/20238,000 shares $40,160.00 -28.6%0.1%0.5 $5.02 9/30/202311,200 shares $59,806.88 +62.3%0.2%0.7 $5.34 9/15/20236,900 shares $36,984.00 +15.0%0.1%0.4 $5.36 8/31/20236,000 shares $27,660.00 No Change0.1%0.4 $4.61 8/15/20236,000 shares $29,700.00 -11.8%0.1%0.5 $4.95 7/31/20236,800 shares $36,924.00 +11.5%0.1%0.6 $5.43 7/15/20236,100 shares $31,049.00 -3.2%0.1%0.6 $5.09 6/30/20236,300 shares $31,500.00 No Change0.1%0.7 $5.00 6/15/20236,300 shares $34,713.00 -6.0%0.1%0.8 $5.51 5/31/20236,700 shares $31,959.00 -30.2%0.1%0.8 $4.77 5/15/20239,600 shares $47,712.00 No Change0.2%1.1 $4.97 10/31/202210,500 shares $84,105.00 -38.2%0.2%1.3 $8.01 10/15/202217,000 shares $133,620.00 +60.4%0.3%2 $7.86 9/30/202210,600 shares $79,288.00 +6.0%0.2%1.2 $7.48 9/15/202210,000 shares $75,700.00 +19.1%0.2%1.1 $7.57 8/31/20228,400 shares $61,236.00 +12.0%0.2%0.9 $7.29 8/15/20227,500 shares $60,450.00 -24.2%0.1%1 $8.06 7/31/20229,900 shares $86,922.00 +32.0%0.2%1.1 $8.78 7/15/20227,500 shares $63,000.00 -13.8%0.1%0.7 $8.40 6/30/20228,700 shares $75,603.00 +24.3%0.2%0.8 $8.69 6/15/20227,000 shares $56,840.00 +1.5%0.1%0.6 $8.12 5/31/20226,900 shares $55,959.00 No Change0.1%0.6 $8.11 5/15/20226,900 shares $55,959.00 -45.2%0.1%0.6 $8.11 4/30/202212,600 shares $122,724.00 +41.6%0.2%1.1 $9.74 4/15/20228,900 shares $79,655.00 -22.6%0.2%0.8 $8.95 3/31/202211,500 shares $110,975.00 +21.1%N/A1.1 $9.65 3/15/20229,500 shares $82,270.00 +50.8%0.2%0.9 $8.66 2/28/20226,300 shares $51,471.00 -24.1%0.1%0.6 $8.17Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ICCC Short Interest - Frequently Asked Questions What is ImmuCell's current short interest? Short interest is the volume of ImmuCell shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 4,500 shares of ICCC short. 0.08% of ImmuCell's shares are currently sold short. Learn More on ImmuCell's current short interest. What is a good short interest ratio for ImmuCell? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ICCC shares currently have a short interest ratio of 1.0. Learn More on ImmuCell's short interest ratio. What is a good short interest percentage for ImmuCell? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of ImmuCell's floating shares are currently sold short. Is ImmuCell's short interest increasing or decreasing? ImmuCell saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 4,500 shares, a decrease of 26.2% from the previous total of 6,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImmuCell's float size? ImmuCell currently has issued a total of 7,820,000 shares. Some of ImmuCell's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmuCell currently has a public float of 5,580,000 shares. How does ImmuCell's short interest compare to its competitors? 0.08% of ImmuCell's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ImmuCell: Aspira Women's Health Inc. (2.52%), ARCA biopharma, Inc. (39.55%), OncoCyte Co. (3.08%), Cardio Diagnostics Holdings, Inc. (2.91%), Trinity Biotech plc (0.03%), Biomerica, Inc. (0.39%), Alpha Teknova, Inc. (0.45%), Achieve Life Sciences, Inc. (2.08%), Natural Alternatives International, Inc. (0.24%), ProMIS Neurosciences, Inc. (0.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ImmuCell stock? Short selling ICCC is an investing strategy that aims to generate trading profit from ImmuCell as its price is falling. ICCC shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImmuCell? A short squeeze for ImmuCell occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ICCC, which in turn drives the price of the stock up even further. How often is ImmuCell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ICCC, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: AWH Short Squeeze ABIO Short Squeeze OCX Short Squeeze CDIO Short Squeeze TRIB Short Squeeze BMRA Short Squeeze TKNO Short Squeeze ACHV Short Squeeze NAII Short Squeeze PMN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ICCC) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry